World Health Organization has prequalified Coartem (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and young infants – Novartis
Novartis announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and young infants weighing from 2… read more.
